BAL 0.04% $12.88 bellamy's australia limited

CFDA/SAMR, page-198

  1. 19 Posts.
    If you think the license is going to be granted. Which there is no logical reason it won't be.

    Temporary pain. Long-term gain.
    Last edited by shane.kris: 11/09/18
 
watchlist Created with Sketch. Add BAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.